en

PRODUCT DETAIL

Zilbrysq 16,6 mg injekčný roztok v naplnenej injekčnej striekačke

Code 5174E
MA number EU/1/23/1764/001
Product Form: sol inj 7x0,416 ml/16,6 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AJ Complement inhibitors
L04AJ06 Zilucoplan
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 01.12.2023
Validity: 01.12.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 13.12.2023
eu-flag.png sk-flag.png